Analystreport

ASLAN PHARMACEUTICALS ADR REP 5 (NASDAQ: ASLN) is now covered by analysts at Leerink Swann. They set a "market perform" rating on the stock.

ASLAN Pharmaceuticals Limited - American Depositary Shares  (ASLN) 
US:NASDAQ Investor Relations: ir.aslanpharma.com